Skip to content

Increasing Equity in Lung Cancer Screening

Increasing Equity in Lung Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06360822
Acronym
LUCARE
Enrollment
144
Registered
2024-04-11
Start date
2023-12-01
Completion date
2028-03-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The overall objective of this mixed methods study is to: 1) Refine the Emergency Department Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy, acceptability, and feasibility; and 3) provide an in-depth description of stakeholders' experiences with the ED-LCS intervention for future refinement.

Interventions

BEHAVIORALED-LCS

This is a lung cancer educational intervention for patients in the emergency department.

Sponsors

Indiana University
Lead SponsorOTHER
Eskenazi Health
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* • Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years)

Exclusion criteria

* • Non-English/Spanish speaking * Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment * Intoxicated with alcohol or drugs * Cannot provide reliable follow up contact information (cell phone) * Presenting to the ED with a life-threatening condition * Have received chest CT scan in past 12 months * Already enrolled in LCS * Hospice enrolled

Design outcomes

Primary

MeasureTime frame
Rate of patients receive Lung Cancer Screening6-12 months

Secondary

MeasureTime frameDescription
Patients ratings of interventionAt deliveryThis is a subjective rating provided by patients of the intervention received

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026